Anzar I, Malone B, Samarakoon P, Vardaxis I, Simovski B, Fontenelle H, Meza-Zepeda LA, Stratford R, Keung EZ, Burgess M, Tawbi HA, Myklebost O, Clancy T(2023) The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition Front Immunol, 14, 1226445 DOI 10.3389/fimmu.2023.1226445, PubMed 37799721
Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA(2023) Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential Mol Oncol, 17(11), 2432-2450 DOI 10.1002/1878-0261.13514, PubMed 37622176
Ballinger ML, Pattnaik S, Mundra PA, Zaheed M, Rath E, Priestley P, Baber J, Ray-Coquard I, Isambert N, Causeret S, van der Graaf WTA, Puri A, Duffaud F, Le Cesne A, Seddon B, Chandrasekar C, Schiffman JD, Brohl AS, James PA, Kurtz JE, Penel N, Myklebost O, Meza-Zepeda LA, Pickett H, Kansara Met al.(2023) Heritable defects in telomere and mitotic function selectively predispose to sarcomas Science, 379(6629), 253-260 DOI 10.1126/science.abj4784, PubMed 36656928